tiprankstipranks
Advertisement
Advertisement

APVO Stock Latest News

Aptevo Therapeutics reports Q1 cash and cash equivalents $14.5M
The FlyAptevo Therapeutics reports Q1 cash and cash equivalents $14.5M
3d ago
APVO
Aptevo reports 87% clinical benefit in frontline AML patients in RAINIER trial
PremiumThe Fly
Aptevo reports 87% clinical benefit in frontline AML patients in RAINIER trial
9d ago
APVO
Aptevo Highlights Strong Phase 1b AML Trial Results
PremiumCompany Announcements
Aptevo Highlights Strong Phase 1b AML Trial Results
10d ago
8K
APVO
Aptevo Therapeutics reports FY25 EPS ($87.27) vs. ($31,460.23) last year
PremiumThe Fly
Aptevo Therapeutics reports FY25 EPS ($87.27) vs. ($31,460.23) last year
2M ago
APVO
Aptevo Therapeutics sees cash runway into 4Q26
PremiumThe Fly
Aptevo Therapeutics sees cash runway into 4Q26
2M ago
APVO
Aptevo Reports Promising Interim Data for AML Therapy
PremiumCompany AnnouncementsAptevo Reports Promising Interim Data for AML Therapy
2M ago
8K
APVO
Aptevo Therapeutics announces interim data for mipletamig combination
Premium
The Fly
Aptevo Therapeutics announces interim data for mipletamig combination
2M ago
APVO
Aptevo Therapeutics Shareholders Approve Expanded Equity Financing Capacity
Premium
Company Announcements
Aptevo Therapeutics Shareholders Approve Expanded Equity Financing Capacity
3M ago
8K
APVO
Aptevo Therapeutics Announces CEO Transition and Leadership Changes
PremiumCompany Announcements
Aptevo Therapeutics Announces CEO Transition and Leadership Changes
3M ago
8K
APVO
Aptevo Therapeutics CEO Marvin White to retire, assume Executive Chair role
PremiumThe Fly
Aptevo Therapeutics CEO Marvin White to retire, assume Executive Chair role
3M ago
APVO
Aptevo Therapeutics files to sell 7.075M shares of common stock for holders
PremiumThe Fly
Aptevo Therapeutics files to sell 7.075M shares of common stock for holders
4M ago
APVO
Aptevo Therapeutics Secures $60 Million Equity Financing Facility
PremiumCompany Announcements
Aptevo Therapeutics Secures $60 Million Equity Financing Facility
4M ago
8K
APVO
Aptevo Therapeutics secures $60M equity line of credit
PremiumThe FlyAptevo Therapeutics secures $60M equity line of credit
4M ago
APVO
Aptevo Therapeutics trading halted, news pending
Premium
The Fly
Aptevo Therapeutics trading halted, news pending
5M ago
APVO
Aptevo Therapeutics Implements 1-for-18 Reverse Stock Split
Premium
Company Announcements
Aptevo Therapeutics Implements 1-for-18 Reverse Stock Split
5M ago
8K
APVO
Upcoming Stock Splits This Week (December 29 to January 2) – Stay Invested
PremiumMarket News
Upcoming Stock Splits This Week (December 29 to January 2) – Stay Invested
5M ago
WOK
ACET
Aptevo Therapeutics Announces Promising RAINIER Trial Results
PremiumCompany Announcements
Aptevo Therapeutics Announces Promising RAINIER Trial Results
5M ago
8K
APVO
Aptevo Therapeutics presents preliminary results from Phase 1b/2 RAINIER study
PremiumThe Fly
Aptevo Therapeutics presents preliminary results from Phase 1b/2 RAINIER study
5M ago
APVO
Aptevo Therapeutics debuts trispecific antibody candidate APVO451
PremiumThe Fly
Aptevo Therapeutics debuts trispecific antibody candidate APVO451
6M ago
APVO
Aptevo Therapeutics management to meet virtually with Roth Capital
PremiumThe FlyAptevo Therapeutics management to meet virtually with Roth Capital
6M ago
APVO
Aptevo Therapeutics reports Q3 EPS ($2.23) vs. ($357.86) last year
Premium
The Fly
Aptevo Therapeutics reports Q3 EPS ($2.23) vs. ($357.86) last year
6M ago
APVO
Aptevo Therapeutics sees cash runway into 4Q26
Premium
The Fly
Aptevo Therapeutics sees cash runway into 4Q26
6M ago
APVO

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >